#234 Dexcom CEO Kevin Sayer Returns

G6 Enhancements

The Dexcom G6 system has seen significant upgrades, enhancing its ease of use and reliability. Kevin Sayer emphasizes the emotional response from users, highlighting the system's no-calibration feature and improved sensor stability 1. He notes, "The response when I would ask people, tell me about your gen six experience, was literally more emotional than anyone I've ever had" 1. The company is also focused on doubling sensor production capacity to increase accessibility 1. Algorithm updates and new sensor membrane materials are being explored to further improve performance 2.

   

G7 Innovations

The upcoming Dexcom G7 model promises to be a major leap forward in diabetes management technology. Kevin Sayer reveals that the G7 will be significantly smaller and thinner, with a longer wear period and fewer steps for use 3. He shares, "It is going to be as big a step forward as G6 was over G5" 1. The G7's development involves new electronics and mechanical designs, aiming to enhance user experience and meet FDA accuracy standards 3.

   

Apple Watch

Dexcom is actively working on integrating its technology with the Apple Watch, a feature highly anticipated by users. Kevin Sayer explains that this integration requires new firmware and Bluetooth interfaces, and will be rolled out gradually 4. He mentions, "One day you're all going to wake up and direct to Apple Watch is going to be there" 4. This development reflects Dexcom's open culture and commitment to enhancing user experience through innovative solutions 5.